Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $16.5 million.

  • Tandem Diabetes Care's Other Non-Current Assets fell 5467.12% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year decrease of 5467.12%. This contributed to the annual value of $5.2 million for FY2024, which is 8719.26% down from last year.
  • Latest data reveals that Tandem Diabetes Care reported Other Non-Current Assets of $16.5 million as of Q3 2025, which was down 5467.12% from $17.3 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Other Non-Current Assets registered a high of $40.3 million during Q4 2023, and its lowest value of $5.2 million during Q4 2024.
  • Its 5-year average for Other Non-Current Assets is $20.4 million, with a median of $16.6 million in 2021.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 38836.82% in 2021, then plummeted by 8719.26% in 2024.
  • Tandem Diabetes Care's Other Non-Current Assets (Quarter) stood at $15.7 million in 2021, then surged by 50.25% to $23.6 million in 2022, then soared by 70.69% to $40.3 million in 2023, then plummeted by 87.19% to $5.2 million in 2024, then skyrocketed by 219.8% to $16.5 million in 2025.
  • Its last three reported values are $16.5 million in Q3 2025, $17.3 million for Q2 2025, and $7.5 million during Q1 2025.